Literature DB >> 27398827

The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.

Carlos M Luna1, Ileana Palma1, Michael S Niederman2, Evangelina Membriani1, Vanina Giovini1, Timothy L Wiemken3, Paula Peyrani3, Julio Ramirez3.   

Abstract

RATIONALE: Comorbidities, age, severity of illness, and high risk pathogens are well-known outcome determinants in community-acquired pneumonia (CAP). How these factors interact has not yet been clarified.
OBJECTIVES: We conducted this study to analyze the complex interaction of comorbidities, age, illness severity, and pathogens in relation to CAP.
METHODS: We performed a secondary analysis of the Community-Acquired Pneumonia Organization database to evaluate the impact of age in different age groups (<65, 65-79, and ≥80 yr), comorbidities (malignant disease, chronic obstructive pulmonary disease, renal and liver disease, cerebrovascular accident, congestive heart failure, and diabetes mellitus), severity of illness at admission, and etiology on the mortality of patients admitted to the hospital with CAP.
MEASUREMENTS AND MAIN RESULTS: A total of 6,205 patients met the inclusion criteria, and 508 (8.2%) died within 30 days. Factors independently associated with mortality were malignant disease, congestive heart failure, cerebrovascular accident, renal disease, diabetes mellitus, altered mental status, hypoxemia, pleural effusion, hematocrit less than 30%, requirement for mechanical ventilation, and being age 80 years and older. A total of 1,699 pathogens were defined in 1,545 cases; the etiology was the same for all age groups. In the overall population, mortality increased with age, but etiology was not associated with mortality. When we analyzed the patients with one comorbidity or less, we found that mortality was not different between patients younger than 65 old and those 65-79 years old, but it was higher for those aged 80 years and older.
CONCLUSIONS: The presence of comorbidities is associated with poorer outcomes in CAP. However, when one comorbidity or less was present, we found that being age 80 years or older was a factor that increased mortality. From a clinical standpoint, this study suggests that being age 80 years or older, instead of age 65 years and older, should be considered a risk factor for poor outcome in CAP.

Entities:  

Keywords:  age; aging; community-acquired pneumonia; comorbidities; mortality

Mesh:

Year:  2016        PMID: 27398827     DOI: 10.1513/AnnalsATS.201512-848OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  25 in total

Review 1.  [Antipyretics in intensive care patients].

Authors:  A Simon; A Leffler
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

Review 2.  The status of intensive care medicine research and a future agenda for very old patients in the ICU.

Authors:  H Flaatten; D W de Lange; A Artigas; D Bin; R Moreno; S Christensen; G M Joynt; Sean M Bagshaw; C L Sprung; D Benoit; M Soares; B Guidet
Journal:  Intensive Care Med       Date:  2017-02-25       Impact factor: 17.440

3.  Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.

Authors:  Thomas M File; Elizabeth Alexander; Lisa Goldberg; Anita F Das; Christian Sandrock; Susanne Paukner; Gregory J Moran
Journal:  BMC Pulm Med       Date:  2021-05-08       Impact factor: 3.317

4.  Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.

Authors:  Luis A Ruiz; Pedro P España; Ainhoa Gómez; Amaia Bilbao; Carmen Jaca; Amaia Arámburu; Alberto Capelastegui; Marcos I Restrepo; Rafael Zalacain
Journal:  BMC Geriatr       Date:  2017-06-20       Impact factor: 3.921

5.  Hospitalisation with community-acquired pneumonia among patients with type 2 diabetes: an observational population-based study in Spain from 2004 to 2013.

Authors:  Ana López-de-Andrés; Javier de Miguel-Díez; Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Napoleón Pérez-Farinós; Miguel Á Ngel Salinero-Fort; Rodrigo Jiménez-García
Journal:  BMJ Open       Date:  2017-01-05       Impact factor: 2.692

6.  Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study.

Authors:  Virginie Prendki; Max Scheffler; Benedikt Huttner; Nicolas Garin; François Herrmann; Jean-Paul Janssens; Christophe Marti; Sebastian Carballo; Xavier Roux; Christine Serratrice; Jacques Serratrice; Thomas Agoritsas; Christoph D Becker; Laurent Kaiser; Sarah Rosset-Zufferey; Valérie Soulier; Arnaud Perrier; Jean-Luc Reny; Xavier Montet; Jérôme Stirnemann
Journal:  Eur Respir J       Date:  2018-05-30       Impact factor: 16.671

7.  The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States.

Authors:  Rodrigo Cavallazzi; Stephen Furmanek; Forest W Arnold; Leslie A Beavin; Richard G Wunderink; Michael S Niederman; Julio A Ramirez
Journal:  Chest       Date:  2020-04-13       Impact factor: 10.262

8.  Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.

Authors:  Aaron D Storms; Jufu Chen; Lisa A Jackson; James D Nordin; Allison L Naleway; Jason M Glanz; Steven J Jacobsen; Eric S Weintraub; Nicola P Klein; Paul M Gargiullo; Alicia M Fry
Journal:  BMC Pulm Med       Date:  2017-12-16       Impact factor: 3.317

9.  Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.

Authors:  Xiudi Han; Fei Zhou; Hui Li; Xiqian Xing; Liang Chen; Yimin Wang; Chunxiao Zhang; Xuedong Liu; Lijun Suo; Jinxiang Wang; Guohua Yu; Guangqiang Wang; Xuexin Yao; Hongxia Yu; Lei Wang; Meng Liu; Chunxue Xue; Bo Liu; Xiaoli Zhu; Yanli Li; Ying Xiao; Xiaojing Cui; Lijuan Li; Jay E Purdy; Bin Cao
Journal:  BMC Infect Dis       Date:  2018-04-24       Impact factor: 3.090

Review 10.  Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  De-Shun Liu; Xiu-Di Han; Xue-Dong Liu
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.